Drugs / Saccharated Ferric Oxide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02731534 Comparator | May 2016 → Mar 2017 | iron deficiency anemia | Zeria Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saccharated Ferric Oxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02731534 ↗ |
| Route | Intravenous | “IV two or three times per week” NCT02731534 ↗ |